Compass Therapeutics, Inc.
CMPX
$1.78
$0.031.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.19% | -17.42% | -10.68% | -13.89% | -8.33% |
| Total Depreciation and Amortization | -7.25% | -2.31% | -3.32% | -4.00% | -0.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 138.74% | 127.34% | 74.21% | 8.09% | -35.10% |
| Change in Net Operating Assets | -42.43% | -196.50% | 62.53% | 36.53% | -130.25% |
| Cash from Operations | -10.43% | -23.50% | 2.29% | -10.06% | -19.03% |
| Capital Expenditure | -46.67% | 29.33% | 79.35% | -66.67% | 85.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.42% | 245.71% | 161.68% | 112.68% | 117.86% |
| Cash from Investing | 73.45% | 245.09% | 161.50% | 112.67% | 117.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 468.16% | -77.20% | -77.17% | -72.13% | -95.82% |
| Repurchase of Common Stock | -45.91% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -477.66% | 7.80% | 8.14% | -28.89% | 81.01% |
| Cash from Financing | 490.73% | -78.09% | -78.06% | -73.18% | -96.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 279.65% | -50.21% | 101.81% | 96.93% | 90.22% |